Hexethal: Difference between revisions
CSV import |
No edit summary |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
<gallery> | <gallery> | ||
File:Sodium Hexethal.svg|Hexethal | File:Sodium Hexethal.svg|Hexethal | ||
</gallery> | </gallery> | ||
Latest revision as of 23:48, 16 March 2025
Hexethal is a barbiturate derivative that was first synthesized in the early 20th century. It is a white, crystalline substance that is soluble in water and alcohol. Hexethal has been used as a sedative and anesthetic, but its use has declined due to the development of safer alternatives.
History[edit]
Hexethal was first synthesized in 1925 by the German chemist Adolf Windaus. It was initially used as a sedative and anesthetic in medical procedures. However, its use declined in the mid-20th century due to the development of safer alternatives.
Pharmacology[edit]
Hexethal is a barbiturate, a class of drugs that act as central nervous system depressants. It works by increasing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits brain activity. This results in a decrease in brain activity, leading to sedation and loss of consciousness.
Medical uses[edit]
Hexethal has been used as a sedative and anesthetic in medical procedures. However, its use has declined due to the development of safer alternatives.
Side effects[edit]
Like other barbiturates, hexethal can cause a range of side effects, including drowsiness, dizziness, and confusion. In severe cases, it can cause respiratory depression, coma, and death.


